← FDA DRUG APPROVALS
FDA ANDA · ANDA075430
CLOBETASOL PROPIONATE (EMOLLIENT)
clobetasol propionate
Sponsor: FOUGERA PHARMS
APPLICATION
ANDA075430
TYPE
ANDA
ORIGINAL APPROVAL
1999-05-26
LATEST ACTION
2018-05-21
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
CLOBETASOL PROPIONATE (EMOLLIENT)Prescription
CLOBETASOL PROPIONATE 0.05% · CREAM · TOPICAL
Approval history
2018-05-21Labeling · Supplement 7 · standardAP
2007-03-16Labeling · Supplement 4AP
1999-06-14Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.